Parkinson's Disease, adaptive DBS and FDA

FDA Approves Adaptive Deep Brain Stimulator for Parkinson's Disease
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode identifier) for people with Parkinson's disease, Medtronic announced Monday. Like other DBS devices,
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
FDA OKs First Adaptive DBS System for Parkinson’s Disease
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized neuromodulation that responds to the patient’s changing needs.
Medtronic Parkinson's Disease Brain Stimulation System Gets FDA Approval
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
FDA approves Medtronic’s adaptive technology for Parkinson’s
The company's adaptive deep brain stimulation technology for Parkinson's disease therapy is expected to be available nationwide in the next few months.
FDA Approves Medtronic’s BrainSense Adaptive Deep Brain Stimulation for Parkinson Disease
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real-time brain activity to improve Parkinson disease symptom control without manual adjustments.
In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive technology personalizing treatment of Parkinson’s symptoms using advanced stimulation deep in the brain.
Medtronic's deep brain stimulation system for Parkinson's disease wins FDA nod
Medtronic's FDA-approved BrainSense Adaptive DBS system revolutionizes Parkinson's therapy with real-time adjustments for personalized symptom control.
emjreviews.com11m
Tramadol and Parkinson’s: New Pain Insights
New research finds chronic pain is five times more common in patients with Parkinson’s disease compared to age-matched ...
Studies of Parkinson’s disease have long overlooked Pacific populations – our work shows why that must change
A form of Parkinson’s disease caused by mutations in a gene known as PINK1 has long been labelled rare. But our research ...
Jake Paul causes Mike Tyson Parkinson’s disease stir in wild interview after controversial fight
The Tyson-Paul fight had to be re-scheduled from July 20 to Nov. 15 after Tyson had a medical emergency on a plane during the ...
News Medical on MSN6d
Cholesterol metabolite linked to Parkinson's disease development in mice
Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical ...
Mike Tyson Sets Record Straight On Parkinson’s Disease Rumors
Mike Tyson is setting the record straight amid rumors he has Parkinson's Disease following comments made by Jake Paul.   The ...
Director Lars von Trier admitted to care facility for Parkinson’s disease
Danish film director Lars von Trier has been admitted to a care facility for Parkinson’s disease, his producer said Wednesday ...
Parkinson’s Patients Have a New Way to Manage Their Symptoms
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
News Medical on MSN6h
This new treatment can adjust to Parkinson's symptoms in real time
Starting today, people with Parkinson’s disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.